My Cart [ 0 ]
Home > Cell Biology > Stable Cell Lines > BeneFIX Biosimilar Stable Cell Line

BeneFIX Biosimilar Stable Cell Line

Recombinant Factor IX, Christmas factor

Catalog No. Product Name Size List Price (US$) Quantity
C019 BeneFIX Biosimilar Stable Cell Line 1 package Request
Description

BeneFIX, recombinant factor IX, is used to treat hemophilia B. Lack of Factor IX (Christmas factor), one of the serine proteases of the coagulation system, causes hemophilia B, a recessive X-linked genetic disorder and about 20% of haemophilia cases.

C019: BeneFIX Biosimilar Stable Cell Line (CHO)

The yield of BeneFIX biosimilar from the CHO stable cell line was above 20 IU/mL in a 15 liter manufacturing.

The BeneFIX biosimilar stable cell line alone can be transferred alone or together with the technology of process development and/or antibody purification.

Syd Labs also provides the following clotting or coagulation-related biosimilar stable cell lines:
Advate / Kogenate Biosimilar Stable Cell Line (Factor VIII)
ReFacto Biosimilar Stable Cell Line (truncated Factor VIII)
NovoSeven Biosimilar Stable Cell Line (Factor VIIa)

Related Links

See our Privacy Policy